---
figid: PMC11011631__ijms-25-03876-g001
figtitle: 'Targeting HER2 in Gastroesophageal Adenocarcinoma: Molecular Features and
  Updates in Clinical Practice'
organisms:
- NA
organisms_ner:
- Danio rerio
- Homo sapiens
pmcid: PMC11011631
filename: ijms-25-03876-g001.jpg
figlink: /pmc/articles/PMC11011631/figure/ijms-25-03876-f001/
number: F1
caption: The figure represents the HER2 signalling pathway and the extra- and intra-cellular
  binding site of anti-HER2 drugs. HER2 receptor is composed of four extracellular
  domains identified as I, III, III, and IV.
papertitle: 'Targeting HER2 in Gastroesophageal Adenocarcinoma: Molecular Features
  and Updates in Clinical Practice.'
reftext: Maria Bonomi, et al. Int J Mol Sci. 2024 Apr;25(7):3876.
year: '2024'
doi: 10.3390/ijms25073876
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: gastroesophageal adenocarcinoma | HER2 | immunotherapy | trastuzumab | trastuzumab
  deruxtecan | ct-DNA | heterogeneity
automl_pathway: 0.9731104
figid_alias: PMC11011631__F1
figtype: Figure
redirect_from: /figures/PMC11011631__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11011631__ijms-25-03876-g001.html
  '@type': Dataset
  description: The figure represents the HER2 signalling pathway and the extra- and
    intra-cellular binding site of anti-HER2 drugs. HER2 receptor is composed of four
    extracellular domains identified as I, III, III, and IV.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - her3
  - egfra
  - her2
  - her4.1
  - pdk1
  - rab1ab
  - ERBB3
  - EGFR
  - ERBB2
  - ERBB4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - MTG1
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - GDP
  - GTP
  - RAS
  - MEK
---
